Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) [Phase 3]

View source ↗

Summary

Phase 3 PANOVA-3 trial evaluated tumor treating fields (150 kHz) added to gemcitabine and nab-paclitaxel as front-line therapy for locally advanced pancreatic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: NovoCure Ltd. | Conditions: Pancreas Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2026-01-21